Cargando…
F224. UTILITY OF SALIVA FOR MONITORING OF CLOZAPINE LEVELS
BACKGROUND: Clozapine has specific indication for use in Treatment Resistant Schizophrenia (TRS) with guidelines for therapeutic drug monitoring. Though a plasma level > 350 ng/ml has been cited as the therapeutic threshold, many other studies have shown poor or inconsistent associations between...
Autores principales: | Lee, Jimmy, Yee, Jie Yin, See, Yuen Mei, Tang, Charmaine, Ng, Boon Tat, Remington, Gary, Chowbay, Balram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888525/ http://dx.doi.org/10.1093/schbul/sby017.755 |
Ejemplares similares
-
M215. FACTORS ASSOCIATED WITH CLOZAPINE RESPONSE AND RESISTANCE IN SCHIZOPHRENIA
por: Lee, Jimmy, et al.
Publicado: (2020) -
Association Between Weight Gain and Remission Status at 3 Months in First-Episode Schizophrenia
por: Oh, Nicholas, et al.
Publicado: (2016) -
T224. THE FUNCTIONAL CONNECTIVITY DERIVED WITH BIVARIATE ANALYSIS, COHERENCE AND PHASE LOCKING VALUE IN PATIENTS WITH SCHIZOPHRENIA UNDER CLOZAPINE
por: Kim, Yong Sik, et al.
Publicado: (2018) -
Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021) -
Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone
por: Liew, Siew Fai, et al.
Publicado: (2021)